REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts19192323
Avg. Estimate10.1910.9541.5943.38
Low estimate8.289.1334.7634.98
High estimate12.7113.147.5750.19
Year ago EPS9.7711.1444.9841.59
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts17162222
Avg. Estimate3.05B3.19B12.68B13.34B
Low estimate2.79B2.95B11.9B11.72B
High estimate3.25B3.34B13.26B14.76B
Year ago sales2.86B2.94B12.17B12.68B
Sales growth (year/est)6.90%8.50%4.10%5.20%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS8.849.4810.039.56
Actual EPS9.7711.1412.5610.09
Difference0.931.662.530.53
Surprise %10.50%17.50%25.20%5.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate10.1910.9541.5943.38
7 days ago10.1910.9541.5943.38
30 days ago10.6110.8941.3644.63
60 days ago10.7410.8941.3845.08
90 days ago10.7410.8741.4745.13
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4375
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.4.30%N/AN/AN/A
Next qtr.-1.70%N/AN/AN/A
Current year-7.50%N/AN/AN/A
Next year4.30%N/AN/AN/A
Next 5 years (per annum)2.80%N/AN/AN/A
Past 5 years (per annum)23.38%N/AN/AN/A